Journal article
Outcomes and predictors of very stable INR control during chronic anticoagulation therapy
Abstract
For patients on warfarin therapy, an international normalized ratio (INR) recall interval not exceeding 4 weeks has traditionally been recommended. Less frequent INR monitoring may be feasible in stable patients. We sought to identify patients with stable INRs (defined as having INR values exclusively within the INR range) and comparator patients (defined as at least one INR outside the INR range) in a retrospective, longitudinal cohort study. …
Authors
Witt DM; Delate T; Clark NP; Martell C; Tran T; Crowther MA; Garcia DA; Ageno W; Hylek EM; Consortium OBOTWARPAOE
Journal
Blood, Vol. 114, No. 5, pp. 952–956
Publisher
American Society of Hematology
Publication Date
July 30, 2009
DOI
10.1182/blood-2009-02-207928
ISSN
0006-4971
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Age FactorsAgedAged, 80 and overAnticoagulantsAtrial FibrillationBlood CoagulationCohort StudiesColoradoComorbidityDiabetes MellitusDrug MonitoringFemaleHeart FailureHeart Valve DiseasesHemorrhageHumansInternational Normalized RatioMaleMiddle AgedRetrospective StudiesThrombophiliaTreatment OutcomeVenous ThrombosisWarfarin